| Literature DB >> 23757500 |
Anindya Sen1, Douglas N Dimlich, K G Guruharsha, Mark W Kankel, Kazuya Hori, Takakazu Yokokura, Sophie Brachat, Delwood Richardson, Joseph Loureiro, Rajeev Sivasankaran, Daniel Curtis, Lance S Davidow, Lee L Rubin, Anne C Hart, David Van Vactor, Spyros Artavanis-Tsakonas.
Abstract
The clinical severity of the neurodegenerative disorder spinal muscular atrophy (SMA) is dependent on the levels of functional Survival Motor Neuron (SMN) protein. Consequently, current strategies for developing treatments for SMA generally focus on augmenting SMN levels. To identify additional potential therapeutic avenues and achieve a greater understanding of SMN, we applied in vivo, in vitro, and in silico approaches to identify genetic and biochemical interactors of the Drosophila SMN homolog. We identified more than 300 candidate genes that alter an Smn-dependent phenotype in vivo. Integrating the results from our genetic screens, large-scale protein interaction studies, and bioinformatic analysis, we define a unique interactome for SMN that provides a knowledge base for a better understanding of SMA.Entities:
Keywords: ALS; disease model; neurodegeneration; neuromuscular junction; proteomics
Mesh:
Substances:
Year: 2013 PMID: 23757500 PMCID: PMC3696827 DOI: 10.1073/pnas.1301738110
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205